Association of G6PD status and haemolytic anaemia in patients receiving anti-malarial agents: a systematic review and meta-analysis

Association of G6PD status and haemolytic anaemia in patients receiving anti-malarial agents: a systematic review and meta-analysis

Abstract Background Some anti-malarial drugs often cause haemolytic anaemia in glucose-6-phosphate-dehydrogenase deficiency (G6PDd) patients. This study aims to analyse the association of G6PDd and anaemia in malaria patients receiving anti-malarial drugs. Methods A literature search was performed i...

Full description

Bibliographic Details
Main Authors:	Erni J. Nelwan, Sharifah Shakinah, Adeline Pasaribu
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Series:	Malaria Journal
Subjects:	Antimalarial G6PD deficiency Primaquine Malaria vivax Malaria falciparum
Online Access:	https://doi.org/10.1186/s12936-023-04493-7

Similar Items

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)
by: Geoffrey Dow, et al.
Published: (2017-05-01)

Evaluation of Plasmodium vivax malaria recurrence in Brazil
by: André Daher, et al.
Published: (2019-01-01)

G6PD deficiency in malaria endemic areas of Nepal
by: Baburam Marasini, et al.
Published: (2020-08-01)

G6PD deficiency in Latin America: systematic review on prevalence and variants
by: Wuelton M Monteiro, et al.
Published: (2014-08-01)

An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia
by: Raffaele Dell’Acqua, et al.
Published: (2017-04-01)

Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania
by: Alphaxard Manjurano, et al.
Published: (2023-12-01)

Incidence of malarial infection and response to antimalarial drugs at Districts Lower Dir and Swat of Khyber Pakhtunkhwa, Pakistan
by: Nasib Zaman, et al.
Published: (2022-12-01)

Assessing the Operational Feasibility of Integrating Point-of-Care G6PD Testing into <i>Plasmodium vivax</i> Malaria Management in Vietnam
by: Emily Gerth-Guyette, et al.
Published: (2023-05-01)

Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry
by: Bharathi Avula, et al.
Published: (2018-08-01)

Subdoses of primaquine in overweight patients and malaria vivax relapses: report of two cases in the Federal District, Brazil Subdoses de primaquina associadas a recaídas de malária vivax em pacientes com peso elevado: relato de dois casos no Distrito Federal
by: João Barberino Santos, et al.
Published: (2010-12-01)

Hemolytic anemia in falciparum and vivax malarial patients based on serum bilirubin examination
by: Yoyoh Yusroh, et al.
Published: (2016-10-01)

Quantitative G6PD Deficiency Screening in Routine Malaria Diagnostic Units in the Brazilian Amazon (SAFEPRIM): An Operational Mixed-Methods Study
by: Jose Diego Brito-Sousa, et al.
Published: (2022-11-01)

Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study
by: Ashenafi Assefa, et al.
Published: (2018-10-01)

Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study
by: Bipin Adhikari, et al.
Published: (2023-03-01)

Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
by: Mac Donald-Ottevanger MS, et al.
Published: (2017-12-01)

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Cindy S. Chu, et al.
Published: (2018-03-01)

Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study
by: Joabi Rocha Nascimento, et al.
Published: (2022-08-01)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
by: André Daher, et al.
Published: (2022-01-01)

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China
by: Wen Zeng, et al.
Published: (2022-10-01)

Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection
by: Damian A. Oyong, et al.
Published: (2019-09-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016-07-01)

Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon
by: Wilson M Ramos Júnior, et al.

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
by: Koukeo Phommasone, et al.
Published: (2020-01-01)

Primaquine in vivax malaria: an update and review on management issues
by: Fernando Deepika, et al.
Published: (2011-12-01)

Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report
by: Deepali Savargaonkar, et al.
Published: (2017-01-01)

A Comparative Study of Clinical Profiles of Vivax and Falciparum Malaria in Children at a Tertiary Care Centre in Uttarakhand
by: Ragini Singh, et al.
Published: (2013-10-01)

The role of private drug vendors as malaria treatment providers in selected malaria endemic areas of Sri Lanka
by: R.S. Rajakaruna, M. Weerasinghe, M. Alifrangis, P.H. Amerasinghe & F. Konradsen
Published: (2006-06-01)

On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR
by: Anatoly V. Kondrashin, et al.
Published: (2018-10-01)

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
by: Ghulam R Awab, et al.
Published: (2021-02-01)

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
by: Kamala Thriemer, et al.
Published: (2017-04-01)

South American monkeys in the development and testing of malarial vaccines - a review
by: William E. Collins
Published: (1992-01-01)

A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India
by: Sundus Shafat Ahmad, et al.
Published: (2024-02-01)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
by: Annisa Rahmalia, et al.
Published: (2023-05-01)

Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
by: Manju Rahi, et al.
Published: (2023-06-01)

Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
by: López-Antuñano Francisco Javier
Published: (1999-01-01)

A clinical tool to predict Plasmodium vivax recurrence in Malaysia
by: Norliza Mat Ariffin, et al.
Published: (2017-12-01)

Management of Plasmodium vivax risk and illness in travelers
by: J. Kevin Baird
Published: (2017-03-01)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
by: A. Taylor Bright, et al.
Published: (2013-05-01)

A Patient with G6PD Deficiency and Falciparum Malaria
by: Y Fagani, et al.
Published: (2007-04-01)

THE MAGNITUDE AND PATTERN OF MALARIA IN DISTRICT KOHAT
by: Aziz Marjan Khattak, et al.
Published: (2014-01-01)